My bookmarksSign up free

Commission Implementing Regulation (EU) 2025/2091 Article 12

Commission Implementing Regulation (EU) 2025/2091 Article 12

General requirements for premises

Article 12

1.   Premises used for the manufacture or import of veterinary medicinal products shall be suitable for the intended operations. In particular, the premises shall be designed or adapted, equipped, operated, cleaned and maintained to minimise the opportunity for extraneous contamination, cross-contamination, the risk of errors and any adverse effect on the quality of the products. 2.   Premises shall be designed and equipped so as to afford maximum protection against the entry of insects or other animals. Measures to prevent the entry of unauthorised people shall be implemented. 3.   Production, storage and quality control areas shall not be used as a right of way by personnel not working in those areas.

Read the full instrument → · Read this in context: CHAPTER IV — PREMISES AND EQUIPMENT →

Other provisions in CHAPTER IV — PREMISES AND EQUIPMENT

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 12 of Commission Implementing Regulation (EU) 2025/2091 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next